Erick Lucera - Apr 3, 2023 Form 3 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Erick Lucera
Stock symbol
SABS
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
3
Date filed
4/5/2023, 05:00 PM
Previous filing
Mar 31, 2023
Next filing
May 18, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.